At the World Health Assembly in May 2022, building on the 2021 resolution on diabetes that included access to insulin, targets, including that by 2030 “100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring” were approved.
To fulfill this target, policies must be put in place that ensure the inclusion of access to insulin and related supplies within Universal Health Coverage and national diabetes programmes. Within this section, you will find reports and case studies that highlight the road to the inclusion of free insulin and sustainable national diabetes programmes in LMICs, and guidelines for transitioning from donor-supported national programmes.
TRANSITION FROM A DONOR-SUPPORTED PROJECT TO A NATIONAL DIABETES PROGRAMME: LESSONS FROM TANZANIA | Policy Brief
Despite some remaining challenges, development of the diabetes programme in Tanzania can in many ways be considered successful and may serve as an example for other countries. In this policy brief an analysis is presented of the factors contributing to its achievements, and a few lessons learnt in the transition.
THE DEVELOPMENT OF A NATIONAL DIABETES PROGRAMME IN TANZANIA | Report
This report traces the development of the National Diabetes Programmes from its beginnings.
COMPANY AND COMPANY SUPPORTED PROGRAMMES WITH A COMPONENT OF DONATED INSULIN IN LMICs | Report
The report looks at the supply of donated insulin through corporate social responsibility and other programmes by the three main insulin-producing companies.
THE IMPORTANCE OF INSULIN DONATIONS FOR CHILDREN IN 43 LOW- AND MIDDLE-INCOME COUNTRIES | Article
H. Hogerzeil, S. Recourt
CASE STUDIES: ROAD TO FREE INSULIN
Here are 6 Case Studies that detail countries road to providing free insulin for those in need.